In last trading session, Lexeo Therapeutics Inc (NASDAQ:LXEO) saw 0.6 million shares changing hands with its beta currently measuring 3.36. Company’s recent per share price
Lexeo Therapeutics Inc (NASDAQ:LXEO)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting 2.83. At the close of
Lexeo Therapeutics Inc (NASDAQ:LXEO)’s traded shares stood at 5.96 million during the last session, with the company’s beta value hitting 2.86. At the close of
In the latest trading session,, 3.38 million Lexeo Therapeutics Inc (NASDAQ:LXEO) shares changed hands as the company’s beta touched 2.86. With the company’s most recent
During the last session, Lexeo Therapeutics Inc. (NASDAQ:LXEO)’s traded shares were 1.15 million. At the end of the trading day, the stock’s price was $8.27,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
